[Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex<sup>®</sup> for patients with premenopausal breast cancer].Xinyu Shao, Zefei Jiang, Qinxin Zhang et al.|PubMed|2025Cited by 0
Abstract P5-07-19: A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in Human Epidermal Growth Factor Receptor 2 positive (HER2+) early breast cancer (EBC) in China: NER-Tree study—An interim analysis on safetyJin Zhang, Xiaojia Wang, Shihui Ma et al.|Clinical Cancer Research|2025Cited by 0